You know what leverage is, it’s when you have something the other party does not and they want it. You may feel that leronlimab is worthless at this point because it does not have any approvals, but this is false. And BP knows the FDA is difficult and basically requires a BP resources to get anything out of. BP is looking at weather the drug works, if it impacts their pipeline and how much. There is plenty of data to show leronlimab works. We have leverage.

Before you bring up the SP as an indication of value, opportunity has not been realized yet, that is why there is potential. That is how investing works. You feel there is value to be had in the future while others don’t. That is the risk, and the potential. If the sp reflected the value of leronlimab, there would be no opportunity.